Organon & Co. (OGN)

Pharmaceutical Preparations

Latest Price

$13.66

TTM P/E

17.51

Normalized P/E

4.67

Div Yield

0.59%

Book Value

3.85

P/B Ratio

3.55

Valuation metrics

EPS: $0.72

Book value / share: $2.89

Formula: √(22.5 × EPS × BVPS)

Graham Number

$6.84

50% downside

Norm. op. income: $1.3B (median of 5yr)

Tax rate: 18%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$10.60

22% downside

EPS: $0.72

Target P/E: 5×

Formula: EPS × P/E

P/E Fair Value

$3.60

74% downside

77.9% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	32.06M	$434.0M	12.21%	+339.8K	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	15.13M	$204.0M	5.76%	-6.71M	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	11.91M	$161.0M	4.54%	+172.8K	2026-06-30
STATE STREET CORP	9.66M	$130.0M	3.68%	-297.4K	2026-06-30
KAHN BROTHERS GROUP INC	5.54M	$33.0M	2.11%	--	2026-06-30
GOLDMAN SACHS GROUP INC	5.20M	$70.0M	1.98%	+3.59M	2026-06-30
UBS Group AG	4.86M	$65.0M	1.85%	+1.38M	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	4.82M	$65.0M	1.83%	+56.3K	2026-06-30
ALLIANCEBERNSTEIN L.P.	4.75M	$28.0M	1.81%	+4.03M	2026-06-30
Man Group plc	4.18M	$56.0M	1.59%	+4.12M	2026-06-30